Radiosensitization of Human Melanoma Cells by Ribozyme-Mediated Inhibition of Survivin Expression
- 1 April 2003
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 120 (4), 648-654
- https://doi.org/10.1046/j.1523-1747.2003.12082.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Role for Survivin in Radioresistance of Pancreatic Cancer CellsJapanese Journal of Cancer Research, 2002
- A Method for Prediction of Accessible Sites on an mRNA Sequence for Target Selection of Hammerhead RibozymesJournal of Computational Biology, 2002
- Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53Journal of Clinical Investigation, 2001
- Cancer gene therapy using a survivin mutant adenovirusJournal of Clinical Investigation, 2001
- Ribozyme gene therapy: applications for molecular medicineTrends in Molecular Medicine, 2001
- Suppression of Vascular Endothelial Growth Factor-Mediated Endothelial Cell Protection by Survivin TargetingThe American Journal of Pathology, 2001
- No longer a molecular black box – new clues to apoptosis and drug resistance in melanomaTrends in Molecular Medicine, 2001
- Survivin as a Radioresistance Factor in Pancreatic CancerJapanese Journal of Cancer Research, 2000
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999
- The chemoresistance of human malignant melanomaMelanoma Research, 1999